Managers
Private equity firm Vance Street Capital has acquired A&E Medical Corporation, a leading medical device OEM designer and contract manufacturer primarily focused on single-use products used in cardiovascular procedures.
This is Vance Street’s first acquisition from its second fund. Terms of the transaction have not been disclosed.
Founded in 1968 and headquartered in Farmingdale, New Jersey, A&E Medical is a leading designer and manufacturer of a high strength sternum closure system along with a wide variety of temporary cardiac pacing wires and extension leads, stainless steel sutures, surgical punches, electrosurgical instruments, and neurosurgical scalp clips.
“A&E Medical is
Natural foods entrepreneur Steve Hughes has formed Sunrise Strategic Partners, in partnership with private equity firm Trilantic North America, to provide growth capital and expertise to emerging brands in the healthy, active and sustainable living space.
Based in Boulder, Colorado, Sunrise will focus on partnering with passionate founders that have a strong, unique vision and are ready to take their business to the next level.
"Trilantic and I share the vision that there is tremendous value to be created by helping founders of brands that resonate with the millennial consumer scale their business," says Steve Hughes co-founder and CEO
Private equity firm Sheridan Capital Partners has made an equity investment in Europa Sports Products (Europa), a wholesale distributor of sports and fitness supplements.
Sheridan will merge the business of its existing portfolio company, Lone Star Distribution, a Dallas-based wholesale distributor of sports and fitness supplements, into the Europa platform.
Europa is a national specialty distributor of sports nutrition and fitness products, including protein powders, nutrition bars, sports drinks, sports performance supplements, vitamins, weight loss supplements, and meal replacements. Europa services mass markets retailers, gyms, health food stores and specialty supplement retailers through seven distribution centers located in Charlotte,
Mid Europa Partners (Mid Europa), a private equity firm focused on Central and Eastern Europe and Turkey, has increased its stake in Walmark to 100 per cent, buying out the founding Walach family.
Walmark is a major Consumer Healthcare player in Central and Eastern Europe with a leading position in dietary supplements in the region. Mid Europa originally acquired a 50 per cent stake in the Company in December 2012.
The transaction was executed by Michelle Capiod, Robert Chmelar, Viktoria Habanova and Tomas Vrba from Mid Europa. White & Case supported Mid Europa in the transaction as legal counsel.
Dynegy and Energy Capital Partners (Energy Capital), through a newly formed joint venture, are to acquire ENGIE’s United States fossil portfolio consisting of 8,731 megawatts of generation capacity located in ERCOT, PJM, and ISO-New England.
The joint venture has secured financing for the USD3.3 billion acquisition, as well as related transaction fees and working capital, with USD2.25 billion in committed debt facilities and USD1.185 billion in equity commitments from its owners, which includes transaction fees and initial cash balance. Dynegy expects the transaction to close in the fourth quarter 2016 after meeting customary closing conditions including approval from the Federal
Lockton Benefit Group has expanded its Private Equity and Corporate Acquisition Practice (PECAP) with the addition of Donald G Harrington, Senior Vice President and director of the practice.
An Associate of Lockton Benefit Group, Harrington is based in New York but has responsibility to integrate the company's private equity transactional services and human capital management of Lockton's clients' businesses across the US. Bob Reiff, President of Lockton Benefit Group said, "Don's background and technical skills are what we needed to lead us into this new chapter."
Ross Reda, Executive Vice President and Chief Operating Officer for Lockton Benefit Group, says:
Quantifind has closed a USD30 million funding round led by global venture capital fund Cathay Innovation. Previous investors Redpoint Ventures, US Venture Partners, Comcast Ventures, Iris Capital and AME Cloud Ventures also joined the round.
This investment will support the company’s growth as it helps marketers understand exactly how their efforts are driving revenue for their respective businesses.
This round of funding, the company’s fourth, will fuel Quantifind’s market expansion efforts, accelerate product development, and allow the company to double staff in its Menlo Park headquarters. Quantifind will focus on growing the sales and customer success teams, as well
PolyPid, an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, has closed a USD22 million private equity financing.
The financing was co-led by new investor Shavit Capital and current investor Aurum Ventures. The round also included participation of Chaim Hurvitz who will now head the Company's board of directors, as well as other existing shareholders. 

The new investment is expected to facilitate the completion of an ongoing confirmatory European clinical trial in severe open tibia fractures for BonyPid-1000™, the company’s proprietary investigational doxycycline-loaded synthetic bone substitute, which is planned to be completed by 2017. The
An affiliate of private equity investment firm HIG Capital has acquired a portfolio of compensation product offerings, including Salary.com, from IBM Corporation.
Founded in 1999 and headquartered in Wellesley, Massachusetts, Salary.com is a provider of reliable information, software, and best practices for compensation professionals. The Company’s product offerings help employers find and analyse detailed, real-time, and accurate information about employee compensation, as well as providing a platform for managing their daily workflow.
William Nolan, Managing Director at HIG, says: “We are excited to have the opportunity to invest in Salary.com and work with Kent Plunkett and his team as
Morgan Stanley Alternative Investment Partners (AIP) has closed on over USD225 million in final capital commitments for Private Markets Income Fund I (PMIF).
The fund’s strategy is to invest in niche income-oriented private market strategies, across primary fund commitments, co-investments and secondaries, which provide near-to-medium-term cash distributions. These investment strategies are frequently backed by real, financial or intellectual property assets. While PMIF represented AIP’s first standalone fund in this strategy, AIP has been an active participant in this investment space since 2000.
“Our clients rely on alternative investments to meet many different objectives, and this capital raise demonstrates how
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
